Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the ‘common soil’ hypothesis

Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes

(2018) Brendan M. Everett et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Differential Associations of Inflammatory Markers With Insulin Sensitivity and Secretion: The Prospective METSIM Study

(2017) Maria Fizelova et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Complement C3 Associates With Incidence of Diabetes, but No Evidence of a Causal Relationship

(2017) Yan Borné et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

White blood cell subtypes and risk of type 2 diabetes

(2017) Hongmei Zhang et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Shared genetic regulatory networks for cardiovascular disease and type 2 diabetes in multiple populations of diverse ethnicities in the United States

(2017) Le Shu et al.   PLoS Genetics

Acute-phase proteins and incidence of diabetes: a population-based cohort study

(2016) Iram Faqir Muhammad et al.   ACTA DIABETOLOGICA

Common dysregulated pathways in obese adipose tissue and atherosclerosis

(2016) V. Moreno-Viedma et al.   Cardiovascular Diabetology

Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes

(2016) Andrew O. Odegaard et al.   Cardiovascular Diabetology

Inflammatory processes in cardiovascular disease: a route to targeted therapies

(2016) Neil Ruparelia et al.   Nature Reviews Cardiology

Elevated serum complement C3 levels are related to the development of prediabetes in an adult population: the Tianjin Chronic Low-Grade Systematic Inflammation and Health Cohort Study

(2015) X. Bao et al.   DIABETIC MEDICINE

Neutrophil:lymphocyte ratio is positively related to type 2 diabetes in a large-scale adult population: a Tianjin Chronic Low-Grade Systemic Inflammation and Health cohort study

(2015) Xiaoyan Guo et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus

(2015) Sofia Enhörning et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Inhibition of complement C3 and fibrinogen interaction: a potential novel therapeutic target to reduce cardiovascular disease in diabetes

(2015) Rhodri King et al.   LANCET

Complement Factor 3 Is Associated With Insulin Resistance and With Incident Type 2 Diabetes Over a 7-Year Follow-up Period: The CODAM Study

(2014) Nick Wlazlo et al.   DIABETES CARE

White blood cell subtypes, insulin resistance and β-cell dysfunction in high-risk individuals - the PROMISE cohort

(2013) Chee-Tin Christine Lee et al.   CLINICAL ENDOCRINOLOGY

Differential white cell count and incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study

(2013) Carlos Lorenzo et al.   DIABETOLOGIA

The Complement Anaphylatoxin C5a Receptor Contributes to Obese Adipose Tissue Inflammation and Insulin Resistance

(2013) J. Phieler et al.   JOURNAL OF IMMUNOLOGY

Lymphocytes in obesity-related adipose tissue inflammation

(2012) A. Chatzigeorgiou et al.   DIABETOLOGIA

Total and differential leucocyte counts in relation to incidence of stroke subtypes and mortality: a prospective cohort study

(2012) E. Zia et al.   JOURNAL OF INTERNAL MEDICINE

Immunological complications of obesity

(2012) Thirumala-Devi Kanneganti et al.   NATURE IMMUNOLOGY

Complement C3 deficiency prevent against the onset of streptozotocin-induced autoimmune diabetes involving expansion of regulatory T cells

(2011) Xiaogang Gao et al.   CLINICAL IMMUNOLOGY

Elevated Liver Function Enzymes Are Related to the Development of Prediabetes and Type 2 Diabetes in Younger Adults: The Bogalusa Heart Study

(2011) Q. M. Nguyen et al.   DIABETES CARE

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

(2010) J. Eugen-Olsen et al.   JOURNAL OF INTERNAL MEDICINE

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

The C3a Anaphylatoxin Receptor Is a Key Mediator of Insulin Resistance and Functions by Modulating Adipose Tissue Macrophage Infiltration and Activation

(2009) Y. Mamane et al.   DIABETES

Using self-rated health for analysing social inequalities in health: a risk for underestimating the gap between socioeconomic groups?

(2009) C Delpierre et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies

(2008) Naveed Sattar et al.   LANCET